Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
Launched by AIN SHAMS UNIVERSITY · Apr 10, 2017
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women undergoing primary IVF/ICSI cycles for tubal factor/unexplained infertility and had blastocyst-stage ET
- Exclusion Criteria:
- • cleavage-stage ET.
- • women who had no good-quality embryos to transfer
- • women who had known poor endometrial receptivity
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mohammed Faris, MD
Principal Investigator
Dar El Teb IVF and Infertility Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials